Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genomic Analysis of Mycobacterium tuberculosis Strains Resistant to Second-Line Anti-Tuberculosis Drugs in Lusaka, Zambia.
Chizimu JY, Solo ES, Bwalya P, Kapalamula TF, Mwale KK, Squarre D, Shawa M, Lungu P, Barnes DA, Yamba K, Mufune T, Chambaro H, Kamboyi H, Munyeme M, Hang'ombe BM, Kapata N, Mukonka V, Chilengi R, Thapa J, Nakajima C, Suzuki Y. Chizimu JY, et al. Among authors: chilengi r. Antibiotics (Basel). 2023 Jun 29;12(7):1126. doi: 10.3390/antibiotics12071126. Antibiotics (Basel). 2023. PMID: 37508222 Free PMC article.
Test negative case-control study of COVID-19 vaccine effectiveness for symptomatic SARS-CoV-2 infection among healthcare workers: Zambia, 2021-2022.
Mweso O, Simwanza J, Malambo W, Banda D, Fwoloshi S, Sinyange N, Yoo YM, Feldstein LR, Kapina M, Mulenga LB, Liwewe MM, Musonda K, Kapata N, Mwansa FD, Agolory S, Bobo P, Hines J, Chilengi R. Mweso O, et al. Among authors: chilengi r. BMJ Open. 2023 Dec 10;13(12):e072144. doi: 10.1136/bmjopen-2023-072144. BMJ Open. 2023. PMID: 38072491 Free PMC article.
Antibiotic prescribing patterns and carriage of antibiotic-resistant Escherichia coli and Enterococcus species in healthy individuals from selected communities in Lusaka and Ndola districts, Zambia.
Yamba K, Mudenda S, Mpabalwani E, Mainda G, Mukuma M, Samutela MT, Lukwesa C, Chizimu J, Kaluba CK, Mutalange M, Chilengi R, Muma JB. Yamba K, et al. Among authors: chilengi r. JAC Antimicrob Resist. 2024 Mar 5;6(2):dlae027. doi: 10.1093/jacamr/dlae027. eCollection 2024 Apr. JAC Antimicrob Resist. 2024. PMID: 38449515 Free PMC article.
Characterization of Rotavirus Strains Responsible for Breakthrough Diarrheal Diseases among Zambian Children Using Whole Genome Sequencing.
Mwape I, Laban NM, Chibesa K, Moono A, Silwamba S, Malisheni MM, Chisenga C, Chauwa A, Simusika P, Phiri M, Simuyandi M, Chilengi R, De Beer C, Ojok D. Mwape I, et al. Among authors: chilengi r. Vaccines (Basel). 2023 Nov 26;11(12):1759. doi: 10.3390/vaccines11121759. Vaccines (Basel). 2023. PMID: 38140164 Free PMC article.
Epstein-Barr Virus Detection in the Central Nervous System of HIV-Infected Patients.
Musukuma-Chifulo K, Siddiqi OK, Chilyabanyama ON, Bates M, Chisenga CC, Simuyandi M, Sinkala E, Dang X, Koralnik IJ, Chilengi R, Munsaka S. Musukuma-Chifulo K, et al. Among authors: chilengi r. Pathogens. 2022 Sep 22;11(10):1080. doi: 10.3390/pathogens11101080. Pathogens. 2022. PMID: 36297137 Free PMC article. Review.
Maternal and Infant Histo-Blood Group Antigen (HBGA) Profiles and Their Influence on Oral Rotavirus Vaccine (RotarixTM) Immunogenicity among Infants in Zambia.
Chauwa A, Bosomprah S, Laban NM, Phiri B, Chibuye M, Chilyabanyama ON, Munsaka S, Simuyandi M, Mwape I, Mubanga C, Chobe MC, Chisenga C, Chilengi R. Chauwa A, et al. Among authors: chilengi r. Vaccines (Basel). 2023 Jul 31;11(8):1303. doi: 10.3390/vaccines11081303. Vaccines (Basel). 2023. PMID: 37631871 Free PMC article.
Prevalence of Diarrhoeagenic Escherichia coli among Children Aged between 0-36 Months in Peri-Urban Areas of Lusaka.
Mwape K, Bosomprah S, Chibesa K, Silwamba S, Luchen CC, Sukwa N, Mubanga C, Phiri B, Chibuye M, Liswaniso F, Somwe P, Chilyabanyama O, Chisenga CC, Muyoyeta M, Simuyandi M, Barnard TG, Chilengi R. Mwape K, et al. Among authors: chilengi r. Microorganisms. 2023 Nov 17;11(11):2790. doi: 10.3390/microorganisms11112790. Microorganisms. 2023. PMID: 38004801 Free PMC article.
Safety, tolerability, and immunogenicity of an oral inactivated ETEC vaccine (ETVAX®) with dmLT adjuvant in healthy adults and children in Zambia: An age descending randomised, placebo-controlled trial.
Sukwa N, Mubanga C, Hatyoka LM, Chilyabanyama ON, Chibuye M, Mundia S, Munyinda M, Kamuti E, Siyambango M, Badiozzaman S, Bosomprah S, Carlin N, Kaim J, Sjöstrand B, Simuyandi M, Chilengi R, Svennerholm AM. Sukwa N, et al. Among authors: chilengi r. Vaccine. 2023 Oct 12:S0264-410X(23)01138-6. doi: 10.1016/j.vaccine.2023.09.052. Online ahead of print. Vaccine. 2023. PMID: 37838479 Free article.
160 results